Physician

Jeffry Andrew Goldes, MD

According to 2025 Medicare claims, Jeffry Goldes, MD (NPI: 1871691154) practices dermatology in the Helena, MT market, with the plurality of this provider's patient population coming from Lewis And Clark, MT. This provider's primary affiliated billing organization is ASSOCIATED DERMATOLOGY AND SKIN CANCER CLINIC OF HELENA, PC (NPI: 1497896229; TIN: 810499975) and primary practice location at 59601-4153.

Goldes' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,451 traditional Medicare patients, billed 12,946 HCPCS/CPT codes, and received $921,909 in Medicare payments. The top billing code was 11102 (Biopsy of related skin growth, first growth). Part D data shows 1,838 prescription claims across 463 beneficiaries totaling $1,139,730 in drug costs, led by Dupixent Pen (Dupilumab). Open Payments data shows 43 records totaling $816. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $383,360 to $921,909. Similarly, Part D prescription costs have risen steadily, from $45,845 to $1,139,730. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$461K$922K2015 Medicare payment: $383,360 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $374,540 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $377,559 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $384,472 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $403,289 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $323,845 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $549,130 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $877,249 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $783,903 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $921,909 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,83210,266$383,360
20161,9419,568$374,540
20172,0178,286$377,559
20182,0559,155$384,472
20192,11410,223$403,289
20201,8817,742$323,845
20212,05110,367$549,130
20221,64912,389$877,249
20231,41911,784$783,903
20241,45112,946$921,909

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$570K$1.1M2015 Drug cost: $45,845 (USD; Tot_Drug_Cst)2016 Drug cost: $42,306 (USD; Tot_Drug_Cst)2017 Drug cost: $74,172 (USD; Tot_Drug_Cst)2018 Drug cost: $55,003 (USD; Tot_Drug_Cst)2019 Drug cost: $51,891 (USD; Tot_Drug_Cst)2020 Drug cost: $84,544 (USD; Tot_Drug_Cst)2021 Drug cost: $230,891 (USD; Tot_Drug_Cst)2022 Drug cost: $441,446 (USD; Tot_Drug_Cst)2023 Drug cost: $804,368 (USD; Tot_Drug_Cst)2024 Drug cost: $1,139,730 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015243747$45,845
2016294880$42,306
20173701,174$74,172
20183261,000$55,003
20193451,168$51,891
20203551,333$84,544
20214091,537$230,891
20224371,629$441,446
20234361,672$804,368
20244631,838$1,139,730

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
11102Biopsy of related skin growth, first growth344397$66
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more8321,261$59
88305Pathology examination of tissue using a microscope, intermediate complexity8291,414$53
17000Destruction of precancer skin growth, 1 growth397544$39
17003Destruction of precancer skin growth, 2-14 growths3612,642$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Dupixent PenDupilumab1183,822$517,846
SotyktuDeucravacitinib13390$96,217
OtezlaApremilast19570$92,952
OlumiantBaricitinib15450$82,068
Doxycycline HyclateDoxycycline Hyclate2085,596$8,616

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.43$816E.R. Squibb & Sons, L.L.C.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Jeffry Andrew Goldes, MD?

Tedicare shows public-source Medicare data for Jeffry Andrew Goldes, MD (NPI 1871691154), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jeffry Andrew Goldes, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jeffry Andrew Goldes, MD?

Jeffry Andrew Goldes, MD is linked to ASSOCIATED DERMATOLOGY AND SKIN CANCER CLINIC OF HELENA, PC (billing NPI 1497896229) in the available physician profile data.

Does Jeffry Andrew Goldes, MD have Open Payments data?

Jeffry Andrew Goldes, MD has 43 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.